Dolby Laboratories (DLB) Cash & Equivalents Growth (3y) (2016 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (3y) (Qtr) |
| 1 |
Relx |
81.40 Bn |
81.16 Bn |
- |
-23.67% |
| 2 |
Rentokil Initial |
79.56 Bn |
78.10 Bn |
- |
69.81% |
| 3 |
Cintas |
69.26 Bn |
69.08 Bn |
1.45 Bn |
27.42% |
| 4 |
Copart |
33.09 Bn |
28.01 Bn |
971.24 Mn |
45.36% |
| 5 |
UL Solutions |
20.56 Bn |
20.32 Bn |
381.00 Mn |
- |
| 6 |
Global Payments |
19.88 Bn |
14.69 Bn |
1.70 Bn |
37.85% |
| 7 |
Rb Global |
19.08 Bn |
18.89 Bn |
869.50 Mn |
11.49% |
| 8 |
Aramark |
13.57 Bn |
13.16 Bn |
426.35 Mn |
17.64% |
| 9 |
Amentum Holdings |
5.65 Bn |
5.74 Bn |
345.00 Mn |
- |
| 10 |
Dolby Laboratories |
5.15 Bn |
4.56 Bn |
350.90 Mn |
-4.78% |
| Date | Value |
| Mar 27, 2026 |
-4.78% |
| Dec 26, 2025 |
0.93% |
| Sep 26, 2025 |
4.21% |
| Jun 27, 2025 |
-6.66% |
| Mar 28, 2025 |
-11.38% |
| Dec 27, 2024 |
-21.01% |
| Sep 27, 2024 |
-26.73% |
| Jun 28, 2024 |
-15.28% |
| Mar 29, 2024 |
-13.72% |
| Dec 29, 2023 |
-16.05% |
| Sep 29, 2023 |
-11.41% |
| Jun 30, 2023 |
-3.64% |
| Mar 31, 2023 |
-1.71% |
| Dec 30, 2022 |
-5.48% |
| Sep 30, 2022 |
-8.03% |
| Jul 1, 2022 |
6.23% |
| Apr 1, 2022 |
7.41% |
| Dec 31, 2021 |
10.14% |
| Sep 24, 2021 |
10.10% |
| Jun 25, 2021 |
13.71% |
| Mar 26, 2021 |
16.12% |
| Dec 25, 2020 |
23.01% |
| Sep 25, 2020 |
19.11% |
| Jun 26, 2020 |
13.00% |
| Mar 27, 2020 |
6.95% |
| Dec 27, 2019 |
13.07% |
| Sep 27, 2019 |
15.33% |
| Jun 28, 2019 |
6.10% |
| Mar 29, 2019 |
11.71% |
| Dec 28, 2018 |
19.18% |
| Sep 28, 2018 |
19.95% |
| Jun 29, 2018 |
20.78% |
| Mar 30, 2018 |
14.43% |
| Dec 29, 2017 |
13.39% |
| Sep 29, 2017 |
3.72% |
| Jun 30, 2017 |
0.14% |
| Mar 31, 2017 |
1.37% |
| Dec 30, 2016 |
1.90% |
| Sep 30, 2016 |
4.58% |
| Jul 1, 2016 |
13.67% |